Access cutting-edge major depressive disorder treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access major depressive disorder specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related major depressive disorder treatment provided free
Approximately 240 eligible adult participants (≥18 years old) who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) criteria for Major Depressive Disorder (MDD) will be enrolled. Participants will be randomly assigned to receive a single oral dose of Psilocybin 25 mg, Psilocybin 5 mg, or inactive placebo. The purpose of this study is to evaluate the efficacy, safety, and tolerability of Psilocybin 25 mg versus placebo in adults with MDD, as assessed by the difference between
Sponsor: Usona Institute
Check if you qualify for this major depressive disorder clinical trial in Los Angeles, CA
If you're searching for major depressive disorder treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.